TBPH vs WY · P/E 7.5, rev $38.4M vs P/E 43, rev $3.59B
Theravance Biopharma Inc (TBPH) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the TBPH and WY stock pages for the full models.
Not investment advice.